The Asia Pacific Antimicrobial Susceptibility Testing Market should witness market growth of 6.4% CAGR during the forecast period (2022-2028).
Antimicrobial susceptibility testing devices that are automated are packed with advanced capabilities and are expensive. Moreover, automated antimicrobial susceptibility testing methods offer several benefits, including shortened detection time and testing precision, among others. In addition, antimicrobial susceptibility testing (AST) strives to guarantee that appropriate antibiotics are provided to affected persons and helps to discover resistance isolates with defined resistance mechanisms for infection prevention and control, driving the market growth.
An increasing number of harmful bacteria are developing antibiotic resistance, and new forms of resistance are constantly appearing, necessitating antimicrobial susceptibility testing (AST) as a matter of urgency. Rapid multiplexed AST platforms offer minimum inhibitory concentrations (MICs) within hours at a reasonable cost, enabling rapid determination of effective targeted therapy, resulting in shorter hospital stays, fewer laboratory tests, and a decrease in morbidity, mortality, and associated healthcare costs.
Antimicrobial resistance is being accelerated by the overuse and misuse of antimicrobials by humans and the agricultural sector. With 14 ministries, China released a 2016-2020 One Health National Action Plan to Control Antimicrobial Resistance to establish a clear, multi-sectoral approach to addressing this expanding problem. Hospital inpatient use of antimicrobials has decreased in China due to health officials' efforts, with rates falling from 59.4% in 2011 to 36% in 2019. The antimicrobial susceptibility testing market is anticipated to expand in the region due to the measures taken by the governments of the regional countries.
The China market dominated the Asia Pacific Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $372.2 million by 2028. The Japan market is estimated to grow a CAGR of 5.7% during (2022-2028). Additionally, The India market would experience a CAGR of 7% during (2022-2028).
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End-user, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
Antimicrobial susceptibility testing devices that are automated are packed with advanced capabilities and are expensive. Moreover, automated antimicrobial susceptibility testing methods offer several benefits, including shortened detection time and testing precision, among others. In addition, antimicrobial susceptibility testing (AST) strives to guarantee that appropriate antibiotics are provided to affected persons and helps to discover resistance isolates with defined resistance mechanisms for infection prevention and control, driving the market growth.
An increasing number of harmful bacteria are developing antibiotic resistance, and new forms of resistance are constantly appearing, necessitating antimicrobial susceptibility testing (AST) as a matter of urgency. Rapid multiplexed AST platforms offer minimum inhibitory concentrations (MICs) within hours at a reasonable cost, enabling rapid determination of effective targeted therapy, resulting in shorter hospital stays, fewer laboratory tests, and a decrease in morbidity, mortality, and associated healthcare costs.
Antimicrobial resistance is being accelerated by the overuse and misuse of antimicrobials by humans and the agricultural sector. With 14 ministries, China released a 2016-2020 One Health National Action Plan to Control Antimicrobial Resistance to establish a clear, multi-sectoral approach to addressing this expanding problem. Hospital inpatient use of antimicrobials has decreased in China due to health officials' efforts, with rates falling from 59.4% in 2011 to 36% in 2019. The antimicrobial susceptibility testing market is anticipated to expand in the region due to the measures taken by the governments of the regional countries.
The China market dominated the Asia Pacific Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $372.2 million by 2028. The Japan market is estimated to grow a CAGR of 5.7% during (2022-2028). Additionally, The India market would experience a CAGR of 7% during (2022-2028).
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End-user, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
Scope of the Study
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology & Others
By Method
- Automated Susceptibility Testing Instruments
- Disk Diffusion
- Etest Method
- Agar Diffusion
- Genotyping Method
By Type
- Antibacterial
- Antifungal
- Antiparasitic
- Others
By End-user
- Hospitals & Diagnostic centers
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Clinical Research Organizations
By Product
- Automated Laboratory Instruments
- Manual Laboratory Instruments
- Culture & Growth Media
- Consumables
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- BioMérieux S.A.
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Bruker Corporation
- Accelerate Diagnostics, Inc.
- HiMedia Laboratories Pvt. Ltd.
- F. Hoffmann-La Roche Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Antimicrobial Susceptibility Testing Market by Application
Chapter 5. Asia Pacific Antimicrobial Susceptibility Testing Market by Method
Chapter 6. Asia Pacific Antimicrobial Susceptibility Testing Market by Type
Chapter 7. Asia Pacific Antimicrobial Susceptibility Testing Market by End-user
Chapter 8. Asia Pacific Antimicrobial Susceptibility Testing Market by Product
Chapter 9. Asia Pacific Antimicrobial Susceptibility Testing Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- BioMérieux S.A.
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Bruker Corporation
- Accelerate Diagnostics, Inc.
- HiMedia Laboratories Pvt. Ltd.
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
Related Reports
From
From
Antimicrobial Susceptibility Testing Global Market Report 2024
- Report
- 200 Pages
- Global
From
From
About the Antimicrobial Susceptibility Testing Market
The Antimicrobial Susceptibility Testing (AST) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. AST is used to determine the effectiveness of antibiotics against a particular strain of bacteria, and is used to guide clinical decisions in the treatment of infectious diseases. AST tests are used to identify the most effective antibiotic for a particular infection, and to detect the emergence of antibiotic resistance. AST tests are used in both clinical and research Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
